Interviewing Innovators: A Liquid Biopsy with Dr. Oguzhan Atay, CEO, BillionToOne

What if we could replace every biopsy with a blood test?  …a liquid biopsy.  Systems have accelerated.  It’s now possible to positively impact millions in short time frame. Access is key to our mission. We released our first diagnostic three months ago, and it is 100% reimbursable by Medicaid as well as other major insuranceContinue reading “Interviewing Innovators: A Liquid Biopsy with Dr. Oguzhan Atay, CEO, BillionToOne”